Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENIUS: Gelaspan vs Sterofundin ISO in Severe Sepsis
NCT02715466Phase 4Terminated
- Sponsor
- B. Braun
- Start
- Apr 2016
- Primary completion
- Dec 2021
- Countries
- 5
01
Overview
Phase 4, randomised, double-blind trial of gelatin in sepsis, septic shock and hypovolemia, sponsored by B. Braun. Primary endpoint: Time Until First/Initial Hemodynamic Stabilization at 48 hours. Started Apr 2016; status: terminated.
02
Drugs
gelatin
03
Conditions
sepsisseptic shockhypovolemia
Beyond the preview
Go deeper on NCT02715466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02715466.